BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 12439743)

  • 1. B-Myb overcomes a p107-mediated cell proliferation block by interacting with an N-terminal domain of p107.
    Joaquin M; Bessa M; Saville MK; Watson RJ
    Oncogene; 2002 Nov; 21(52):7923-32. PubMed ID: 12439743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of cyclin A/Cdk2 phosphorylation impairs B-Myb transactivation function without affecting interactions with DNA or the CBP coactivator.
    Bessa M; Saville MK; Watson RJ
    Oncogene; 2001 Jun; 20(26):3376-86. PubMed ID: 11423988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cell cycle-regulated B-Myb transcription factor overcomes cyclin-dependent kinase inhibitory activity of p57(KIP2) by interacting with its cyclin-binding domain.
    Joaquin M; Watson RJ
    J Biol Chem; 2003 Nov; 278(45):44255-64. PubMed ID: 12947099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of the cell cycle by B-Myb.
    Bessa M; Joaquin M; Tavner F; Saville MK; Watson RJ
    Blood Cells Mol Dis; 2001; 27(2):416-21. PubMed ID: 11259164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinoblastoma-related protein pRb2/p130 and its binding to the B-myb promoter increase during human neuroblastoma differentiation.
    Raschellà G; Tanno B; Bonetto F; Amendola R; Battista T; De Luca A; Giordano A; Paggi MG
    J Cell Biochem; 1997 Dec; 67(3):297-303. PubMed ID: 9361185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B-Myb repressor function is regulated by cyclin A phosphorylation and sequences within the C-terminal domain.
    Petrovas C; Jeay S; Lewis RE; Sonenshein GE
    Oncogene; 2003 Apr; 22(13):2011-20. PubMed ID: 12673206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cell-cycle regulated transcription factor B-Myb is phosphorylated by cyclin A/Cdk2 at sites that enhance its transactivation properties.
    Saville MK; Watson RJ
    Oncogene; 1998 Nov; 17(21):2679-89. PubMed ID: 9840932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B-Myb function can be markedly enhanced by cyclin A-dependent kinase and protein truncation.
    Lane S; Farlie P; Watson R
    Oncogene; 1997 May; 14(20):2445-53. PubMed ID: 9188859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinoblastoma family proteins induce differentiation and regulate B-myb expression in neuroblastoma cells.
    Raschellà G; Tanno B; Bonetto F; Negroni A; Amendola R; Paggi MG
    Med Pediatr Oncol; 2001 Jan; 36(1):104-7. PubMed ID: 11464857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of the cyclin D1 and cyclin A1 promoters by B-Myb is mediated by Sp1 binding sites.
    Bartusel T; Schubert S; Klempnauer KH
    Gene; 2005 May; 351():171-80. PubMed ID: 15922873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell cycle regulation by the B-Myb transcription factor.
    Joaquin M; Watson RJ
    Cell Mol Life Sci; 2003 Nov; 60(11):2389-401. PubMed ID: 14625684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Redundant functions of B-Myb and c-Myb in differentiating myeloid cells.
    Golay J; Broccoli V; Borleri GM; Erba E; Faretta M; Basilico L; Ying GG; Piccinini G; Shapiro LH; Lovrić J; Nawrath M; Mölling K; Rambaldi A; Introna M
    Cell Growth Differ; 1997 Dec; 8(12):1305-16. PubMed ID: 9419419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An alternatively spliced isoform of B-Myb is a transcriptional inhibitor.
    Horstmann S; Ferrari S; Klempnauer KH
    Oncogene; 2000 Nov; 19(48):5428-34. PubMed ID: 11114719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-cycle regulation of B-Myb protein expression: specific phosphorylation during the S phase of the cell cycle.
    Robinson C; Light Y; Groves R; Mann D; Marias R; Watson R
    Oncogene; 1996 May; 12(9):1855-64. PubMed ID: 8649845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Lin-9 complex is recruited by B-Myb to activate transcription of G2/M genes in undifferentiated embryonal carcinoma cells.
    Knight AS; Notaridou M; Watson RJ
    Oncogene; 2009 Apr; 28(15):1737-47. PubMed ID: 19252525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The RB-related gene Rb2/p130 in neuroblastoma differentiation and in B-myb promoter down-regulation.
    Raschellà G; Tanno B; Bonetto F; Negroni A; Claudio PP; Baldi A; Amendola R; Calabretta B; Giordano A; Paggi MG
    Cell Death Differ; 1998 May; 5(5):401-7. PubMed ID: 10200489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PARP co-activates B-MYB through enhanced phosphorylation at cyclin/cdk2 sites.
    Santilli G; Cervellera MN; Johnson TK; Lewis RE; Iacobelli S; Sala A
    Oncogene; 2001 Dec; 20(57):8167-74. PubMed ID: 11781832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A B-myb promoter corepressor site facilitates in vivo occupation of the adjacent E2F site by p107 x E2F and p130 x E2F complexes.
    Catchpole S; Tavner F; Le Cam L; Sardet C; Watson RJ
    J Biol Chem; 2002 Oct; 277(41):39015-24. PubMed ID: 12147683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of B-Myb activity by cyclin D1.
    Horstmann S; Ferrari S; Klempnauer KH
    Oncogene; 2000 Jan; 19(2):298-306. PubMed ID: 10645009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclin D1-dependent regulation of B-myb activity in early stages of neuroblastoma differentiation.
    Cesi V; Tanno B; Vitali R; Mancini C; Giuffrida ML; Calabretta B; Raschellà G
    Cell Death Differ; 2002 Nov; 9(11):1232-9. PubMed ID: 12404122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.